Efficacy News and Research

RSS
Additional results from BioSante's LibiGel pK study on HSDD

Additional results from BioSante's LibiGel pK study on HSDD

Non-therapeutic antibiotic usage in food animals creates resistance genes, promotes antibiotic resistance

Non-therapeutic antibiotic usage in food animals creates resistance genes, promotes antibiotic resistance

Mirna reports new preclinical data of miRNA-based therapeutic candidate for hepatocellular carcinoma

Mirna reports new preclinical data of miRNA-based therapeutic candidate for hepatocellular carcinoma

First clinical trial of dapivirine-maraviroc ring to treat HIV in women

First clinical trial of dapivirine-maraviroc ring to treat HIV in women

Rosuvastatin as effective as atorvastatin in reversing atherosclerosis

Rosuvastatin as effective as atorvastatin in reversing atherosclerosis

Researchers to begin drug development projects for rare and neglected diseases

Researchers to begin drug development projects for rare and neglected diseases

International consortium develops first-in-class adiponectin receptor agonist

International consortium develops first-in-class adiponectin receptor agonist

Evacetrapib drug may increase HDL-C and decrease LDL-C levels

Evacetrapib drug may increase HDL-C and decrease LDL-C levels

Moberg Derma receives Vinnova grant to develop Limtop for actinic keratosis, genital warts

Moberg Derma receives Vinnova grant to develop Limtop for actinic keratosis, genital warts

Positive long-term data from Abbott's ABSORB drug eluting BVS trial on CAD

Positive long-term data from Abbott's ABSORB drug eluting BVS trial on CAD

N.J. plans to use managed care system for Medicaid enrollees with mental health problems

N.J. plans to use managed care system for Medicaid enrollees with mental health problems

Mesoblast reports positive Revascor Phase 2 heart failure trial results

Mesoblast reports positive Revascor Phase 2 heart failure trial results

New clues about connections among fat, inflammation and insulin resistance

New clues about connections among fat, inflammation and insulin resistance

Bayer and J&J’s blood thinner drug triumphs at late phase clinical trial

Bayer and J&J’s blood thinner drug triumphs at late phase clinical trial

Yissum Research and other investors complete additional investment round of $3 million in Avraham Pharmaceuticals

Yissum Research and other investors complete additional investment round of $3 million in Avraham Pharmaceuticals

Demand for non-drug intervention for atrial fibrillation will remain, despite FDA PVAC decision

Demand for non-drug intervention for atrial fibrillation will remain, despite FDA PVAC decision

Genzyme's alemtuzumab Phase lll trial on MS meets co-primary endpoints

Genzyme's alemtuzumab Phase lll trial on MS meets co-primary endpoints

Next-generation drugs may prevent skin lesions in BRAF mutation-positive melanoma

Next-generation drugs may prevent skin lesions in BRAF mutation-positive melanoma

Health supplement hope for child muscle disease

Health supplement hope for child muscle disease

Feraheme as safe and effective as iron sucrose in patients with anemia, CKD

Feraheme as safe and effective as iron sucrose in patients with anemia, CKD

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.